864011003: Cabozantinib s-malate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Transferase inhibitor\Phosphotransferase inhibitor\Protein kinase inhibitor\Protein-tyrosine kinase inhibitor\Cabozantinib s-malate
\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Cabozantinib s-malate
\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)\Cabozantinib s-malate

\Drug or medicament (substance)\Enzyme inhibitor\Cabozantinib s-malate
\Drug or medicament (substance)\Antineoplastic agent (substance)\Cabozantinib s-malate
\Drug or medicament (substance)\Quinoline\Cabozantinib s-malate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\...

\Amine and/or amine derivative\Quinoline\Cabozantinib s-malate

\Pyridine and/or pyridine derivative\Pyridine\Cabozantinib s-malate

\Organic compound\Organic cyclic compound\Heterocyclic compound\Pyridine and/or pyridine derivative\Pyridine\Cabozantinib s-malate
\Organic compound\Organic cyclic compound\Heterocyclic compound\Quinoline\Cabozantinib s-malate
\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Quinoline\Cabozantinib s-malate
\Organic compound\Organic nitrogen compound\Pyridine and/or pyridine derivative\Pyridine\Cabozantinib s-malate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3951852016 Cabozantinib s-malate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3951853014 Cabozantinib s-malate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4700391000052119 kabozantinib S-malat sv Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Cabozantinib s-malate	Is a	Enzyme inhibitor	true	Inferred relationship	Some
Cabozantinib s-malate	Is a	Pyridine	true	Inferred relationship	Some
Cabozantinib s-malate	Is a	Quinoline	true	Inferred relationship	Some
Cabozantinib s-malate	Has disposition (attribute)	Protein-tyrosine kinase inhibitor (disposition)	true	Inferred relationship	Some
Cabozantinib s-malate	Is a	Protein-tyrosine kinase inhibitor	true	Inferred relationship	Some
Cabozantinib s-malate	Is modification of (attribute)	Cabozantinib (substance)	true	Inferred relationship	Some
Cabozantinib s-malate	Is a	Antineoplastic agent (substance)	true	Inferred relationship	Some
Cabozantinib s-malate	Has disposition (attribute)	Vascular endothelial growth factor receptor antagonist (disposition)	true	Inferred relationship	Some
Cabozantinib s-malate	Is a	Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Cabozantinib (as cabozantinib s-malate) 20 mg oral capsule	Has precise active ingredient	True	Cabozantinib s-malate	Inferred relationship	Some	1
Product containing precisely cabozantinib (as cabozantinib s-malate) 80 milligram/1 each conventional release oral capsule (clinical drug)	Has precise active ingredient	True	Cabozantinib s-malate	Inferred relationship	Some	1
Cabozantinib (as cabozantinib s-malate) 20 mg oral tablet	Has precise active ingredient	True	Cabozantinib s-malate	Inferred relationship	Some	1
Product containing precisely cabozantinib (as cabozantinib s-malate) 40 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Cabozantinib s-malate	Inferred relationship	Some	1
Product containing precisely cabozantinib (as cabozantinib s-malate) 60 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	Cabozantinib s-malate	Inferred relationship	Some	1

Reference Sets